Article
Estrogen Receptor β Expression and Its Clinical Implication in Breast Cancers: Favorable or Unfavorable?
1 Jan 2022
Abstract excerpt
) in humans. Of those. ERβ, the second ER isotype identified in 1996, is differentially expressed in different phenotypes and molecular subtypes of breast cancer (BCa), and is highly expressed in ERα-negative BCa and triple-negative BCa (TNBC). This review summarizes the potential clinical relevance of ERβ in BCa and the challenges associated with studies on the role of ERβ in BCa. The experimental and clinical...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
